Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
2023 · Molecular Therapy — Nucleic Acids · 54 citations
https://doi.org/10.1016/j.omtn.2023.07.010
D
Dazhou Liao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
300
Citations
11
h-index
11
i10-index
Dazhou Liao is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Pediatric Urology and Nephrology Studies & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 11, co-authored 34 publications.
Papers by this author
worksSR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs
2022 · Cell Death and Disease · 22 citations
https://doi.org/10.1038/s41419-022-05392-6
Sevoflurane activates hippocampal CA3 kainate receptors (Gluk2) to induce hyperactivity during induction and recovery in a mouse model
2017 · British Journal of Anaesthesia · 21 citations
https://doi.org/10.1093/bja/aex043
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
2023 · Military Medical Research · 16 citations
https://doi.org/10.1186/s40779-023-00500-9
Insights into ChatGPT application in renal transplantation
2024 · International Journal of Surgery · 1 citations
https://doi.org/10.1097/js9.0000000000001495
Different inguinal lymphadenectomy for penile malignancy: a pairwise and Bayesian network meta-analysis
2024 · International Journal of Surgery · 1 citations
https://doi.org/10.1097/js9.0000000000001937
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat